171 related articles for article (PubMed ID: 37674426)
1. Coexistence of IgLON5-IgG and SOX1-IgG in a Patient with Progressive Brainstem Dysfunction.
Teekaput C; Teekaput K; Tanprawate S; Kittisares A; Apiwattanakul M
Acta Neurol Taiwan; 2023 Sep; 32(3)():131-135. PubMed ID: 37674426
[TBL] [Abstract][Full Text] [Related]
2. SOX1 antibodies are markers of paraneoplastic Lambert-Eaton myasthenic syndrome.
Sabater L; Titulaer M; Saiz A; Verschuuren J; Güre AO; Graus F
Neurology; 2008 Mar; 70(12):924-8. PubMed ID: 18032743
[TBL] [Abstract][Full Text] [Related]
3. Anti-SOX1 antibody-positive paraneoplastic neurological syndrome presenting with Lambert-Eaton myasthenic syndrome and small cell lung cancer: A case report.
Li C; Wang X; Sun L; Deng H; Han Y; Zheng W
Thorac Cancer; 2020 Feb; 11(2):465-469. PubMed ID: 31880403
[TBL] [Abstract][Full Text] [Related]
4. Anti-SOX1 Antibody-Positive Paraneoplastic Syndrome Presenting with Subacute Cerebellar Degeneration and Lambert-Eaton Myasthenic Syndrome: A Case Report.
Cheng YC; Chang A; Hsu WC
Acta Neurol Taiwan; 2021 Jun; 30(2)():74-77. PubMed ID: 34549392
[TBL] [Abstract][Full Text] [Related]
5. GRP78 antibodies damage the blood-brain barrier and relate to cerebellar degeneration in Lambert-Eaton myasthenic syndrome.
Shimizu F; Takeshita Y; Sano Y; Hamamoto Y; Shiraishi H; Sato T; Yoshimura S; Maeda T; Fujikawa S; Nishihara H; Kitanosono H; Tsujino A; Motomura M; Kanda T
Brain; 2019 Aug; 142(8):2253-2264. PubMed ID: 31236596
[TBL] [Abstract][Full Text] [Related]
6. Expanding the spectrum of SOX1-antibodies in neuropathy: the coexistence of anti-SOX1 and Guillain-Barré syndrome-a case report.
Coniglio S; Turchi G; Giovannini G; Mazzoli M; Meletti S; Vaudano AE
Neurol Sci; 2022 Jun; 43(6):3979-3982. PubMed ID: 35391602
[TBL] [Abstract][Full Text] [Related]
7. SOX1 antibody-related paraneoplastic neurological syndromes: clinical correlates and assessment of laboratory diagnostic techniques.
Vabanesi M; Pinto AL; Vogrig A; Goncalves D; Rogemond V; Joubert B; Fabien N; Honnorat J; Muñiz-Castrillo S
J Neurol; 2023 Mar; 270(3):1691-1701. PubMed ID: 36512064
[TBL] [Abstract][Full Text] [Related]
8. SOX1 antibodies in Lambert-Eaton myasthenic syndrome and screening for small cell lung carcinoma.
Lipka AF; Verschuuren JJ; Titulaer MJ
Ann N Y Acad Sci; 2012 Dec; 1275():70-7. PubMed ID: 23278580
[TBL] [Abstract][Full Text] [Related]
9. [Lambert-Eaton myasthenic syndrome (LEMS)].
Suzuki S
Brain Nerve; 2010 Apr; 62(4):419-26. PubMed ID: 20420183
[TBL] [Abstract][Full Text] [Related]
10. Discordant SOX-1 antibodies results in paraneoplastic Lambert-Eaton syndrome diagnosis by the clinical laboratory.
Pozo-Giraldez A; Rodríguez-Borja E; Diaz-Gimenez M; Carratala-Calvo A; Magro-Pose P; Perez-Griera J
Clin Biochem; 2021 Nov; 97():82-84. PubMed ID: 34450126
[TBL] [Abstract][Full Text] [Related]
11. [A case of anti-SRY-Related HMG-Box Gene 1 (SOX1) antibody-positive chorea].
Yamagishi T; Inoue K; Ouchi H; Shibano K; Hara K
Rinsho Shinkeigaku; 2020 Dec; 60(12):852-856. PubMed ID: 33229831
[TBL] [Abstract][Full Text] [Related]
12. SOX1 antibodies in sera from patients with paraneoplastic neurological syndromes.
Stich O; Klages E; Bischler P; Jarius S; Rasiah C; Voltz R; Rauer S
Acta Neurol Scand; 2012 May; 125(5):326-31. PubMed ID: 21751968
[TBL] [Abstract][Full Text] [Related]
13. SOX antibodies in small-cell lung cancer and Lambert-Eaton myasthenic syndrome: frequency and relation with survival.
Titulaer MJ; Klooster R; Potman M; Sabater L; Graus F; Hegeman IM; Thijssen PE; Wirtz PW; Twijnstra A; Smitt PA; van der Maarel SM; Verschuuren JJ
J Clin Oncol; 2009 Sep; 27(26):4260-7. PubMed ID: 19667272
[TBL] [Abstract][Full Text] [Related]
14. Anti-SOX1 antibodies in patients with paraneoplastic and non-paraneoplastic neuropathy.
Tschernatsch M; Singh P; Gross O; Gerriets T; Kneifel N; Probst C; Malas S; Kaps M; Blaes F
J Neuroimmunol; 2010 Sep; 226(1-2):177-80. PubMed ID: 20701982
[TBL] [Abstract][Full Text] [Related]
15. Clinical manifestations of the anti-IgLON5 disease.
Gaig C; Graus F; Compta Y; Högl B; Bataller L; Brüggemann N; Giordana C; Heidbreder A; Kotschet K; Lewerenz J; Macher S; Martí MJ; Montojo T; Pérez-Pérez J; Puertas I; Seitz C; Simabukuro M; Téllez N; Wandinger KP; Iranzo A; Ercilla G; Sabater L; Santamaría J; Dalmau J
Neurology; 2017 May; 88(18):1736-1743. PubMed ID: 28381508
[TBL] [Abstract][Full Text] [Related]
16. Hypothalamic-Bulbar MRI Hyperintensity in Anti-IgLON5 Disease with Serum-Restricted Antibodies: A Case Report and Systematic Review of Literature.
Tagliapietra M; Frasson E; Cardellini D; Mariotto S; Ferrari S; Zanusso G; Plebani M; Monaco S
J Alzheimers Dis; 2021; 79(2):683-691. PubMed ID: 33337376
[TBL] [Abstract][Full Text] [Related]
17. SOX-1 autoantibodies in patients with paraneoplastic neurological syndromes.
Tschernatsch M; Gross O; Kneifel N; Kaps M; Blaes F
Autoimmun Rev; 2009 Jun; 8(7):549-51. PubMed ID: 19393214
[TBL] [Abstract][Full Text] [Related]
18. Anti-SOX1 Antibodies in Paraneoplastic Neurological Syndrome.
Sun X; Tan J; Sun H; Liu Y; Guan W; Jia J; Wang Z
J Clin Neurol; 2020 Oct; 16(4):530-546. PubMed ID: 33029958
[TBL] [Abstract][Full Text] [Related]
19. A novel non-rapid-eye movement and rapid-eye-movement parasomnia with sleep breathing disorder associated with antibodies to IgLON5: a case series, characterisation of the antigen, and post-mortem study.
Sabater L; Gaig C; Gelpi E; Bataller L; Lewerenz J; Torres-Vega E; Contreras A; Giometto B; Compta Y; Embid C; Vilaseca I; Iranzo A; Santamaría J; Dalmau J; Graus F
Lancet Neurol; 2014 Jun; 13(6):575-86. PubMed ID: 24703753
[TBL] [Abstract][Full Text] [Related]
20. SOX1 autoantibodies: tumor markers in LEMS patients?
Lang B; Evoli A
Neurology; 2008 Mar; 70(12):906-7. PubMed ID: 18347313
[No Abstract] [Full Text] [Related]
[Next] [New Search]
